Early intravenous delivery of human brain stromal cells modulates systemic inflammation and leads to vasoprotection in traumatic spinal cord injury

Stem Cells Translational Medicine

Volumn 5, Issue 8, 2016, Pages 991-1003

  Badner, Anna ^a,b   Vawda, Reaz ^a   Laliberte, Alex ^a,b   Hong, James ^a,b   Mikhail, Mirriam ^a   Jose, Alejandro ^a   Dragas, Rachel ^a,b   Fehlings, Michael ^a,b,c  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

Interleukin 10; Mesenchymal stromal cells; Pericytes; Spinal cord injury; Vasoprotection

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CD146 ANTIGEN; ENDOGLIN; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; EVANS BLUE; HEMOGLOBIN; HERMES ANTIGEN; INTERLEUKIN 10; MICROSOMAL AMINOPEPTIDASE; RANTES; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLEEDING; BLOOD BRAIN BARRIER; BLOOD VESSEL PERMEABILITY; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DNA EXTRACTION; ECHOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; MESENCHYMAL STROMA CELL; MORPHOMETRICS; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; POWER DOPPLER IMAGING; RAT; REAL TIME POLYMERASE CHAIN REACTION; SPINAL CORD INJURY; STEM CELL TRANSPLANTATION; VERY HIGH RESOLUTION ULTRASOUND; ANIMAL; BLOOD FLOW; BRAIN; CELL CULTURE; COMPARATIVE STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; CYTOLOGY; DISEASE MODEL; IMMUNOLOGY; MESENCHYMAL STEM CELL TRANSPLANTATION; METABOLISM; PATHOPHYSIOLOGY; PERICYTE; PHENOTYPE; SPINAL CORD; SPINAL CORD INJURIES; SPLEEN; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TIME FACTOR; TRANSPLANTATION; UMBILICAL CORD; VASCULARIZATION; WISTAR RAT;

ANIMALS; BRAIN; CELLS, CULTURED; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; INTERLEUKIN-10; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; PERICYTES; PHENOTYPE; RATS, WISTAR; REGIONAL BLOOD FLOW; SPINAL CORD; SPINAL CORD INJURIES; SPLEEN; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TIME FACTORS; UMBILICAL CORD;

EID: 84978682966     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2015-0295     Document Type: Article

References (64)

1. Tator CH, Fehlings MG. Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms. J Neurosurg 1991;75:15–26.
2. Rice T, Larsen J, Rivest S et al. Characterization of the early neuroinflammation after spinal cord injury in mice. J Neuropathol Exp Neurol 2007;66:184–195.
3. Schwartz M, Yoles E. Immune-basedtherapy for spinal cord repair: Autologous macrophages and beyond. J Neurotrauma 2006;23:360–370.
4. De Miguel MP, Fuentes-Julián S, Blázquez-Martínez A et al. Immunosuppressive properties of mesenchymal stem cells: Advances and applications. Curr Mol Med 2012;12:574–591.
5. Aertker BM, Bedi S, Cox CS. Strategies for CNS repair following TBI. Exp Neurol 2016;275: 411–426.
6. Menge T, Zhao Y, Zhao J et al. Mesenchymal stem cells regulate blood-brain barrier integrity through TIMP3 release after traumatic brain injury. Sci Transl Med 2012;4:161
7. Zhang R, Liu Y, Yan K et al. Anti-inflammatory and immunomodulatory mechanisms of mesenchymal stem cell transplantation in experimental traumatic brain injury. J Neuroinflammation 2013;10:106.
8. Watanabe J, Shetty AK, Hattiangady B et al. Administration of TSG-6 improves memory after traumatic brain injury in mice. Neurobiol Dis 2013;59:86–99.
9. Walker PA, Shah SK, Jimenez F et al. Intravenous multipotent adult progenitor cell therapy for traumatic brain injury: Preserving the blood brain barrier via an interaction with sple-nocytes. Exp Neurol 2010;225:341–352.
10. Matsushita T, Lankford KL, Arroyo EJ et al. Diffuse and persistent blood-spinal cord barrier disruption after contusive spinalcord injury rapidly recovers following intravenous infusion of bone marrow mesenchymal stem cells. Exp Neurol 2015;267:152–164.
11. Walker PA, Bedi SS, Shah SK et al. Intravenous multipotent adult progenitor cell therapy after traumatic brain injury: Modulation of the resident microglia population. J Neuroinflammation 2012;9:228.
12. Bedi SS, Hetz R, Thomas C et al. Intravenous multipotent adult progenitor cell therapy attenuates activated microglial/macrophage response and improves spatial learning after traumatic brain injury. STEM CELLS TRANSLATIONAL MEDICINE 2013;2:953–960.
13. Devine SM, Bartholomew AM, Mahmud N et al. Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion. Exp Hematol 2001;29:244–255.
14. da Silva Meirelles L, Fontes AM, Covas DT et al. Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev 2009;20:419–427.
15. Liao GP, Harting MT, Hetz RA et al. Autologous bone marrow mononuclear cells reduce therapeutic intensity for severe traumatic brain injury in children. Pediatr Crit Care Med 2015; 16:245–255.
16. Oliveri RS, Bello S, Biering-Sørensen F. Mesenchymal stem cells improve locomotor recovery in traumatic spinal cord injury: Systematic review with meta-analyses of rat models. Neurobiol Dis 2014;62:338–353.
17. Alexanian AR, Kwok W-M, Pravdic D et al. Survival of neurally induced mesenchymal cells may determine degree of motor recovery in injured spinal cord rats. Restor Neurol Neurosci 2010;28:761–767.
18. da Silva Meirelles L, Chagastelles PC, Nardi NB. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 2006;119:2204–2213.
19. Crisan M, Yap S, Casteilla L et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 2008;3:301–313.
20. da Silva Meirelles L, Caplan AI, Nardi NB. In search of the in vivo identity of mesenchymal stem cells. STEM CELLS 2008;26:2287–2299.
21. Hegyi B, Sági B, Kovács J et al. Identical, similar or different? Learning about immunomodulatory function of mesenchymal stem cells isolated from various mouse tissues: Bone marrow, spleen, thymus and aorta wall. Int Immunol 2010;22:551–559.
22. Ivanova-Todorova E, Bochev I, Mourdjeva M et al. Adipose tissue-derived mesenchymal stem cells are more potent suppressors of dendritic cells differentiation compared to bone marrow-derived mesenchymal stem cells. Immunol Lett 2009;126:37–42.
23. Bochev I, Elmadjian G, Kyurkchiev D et al. Mesenchymal stem cells from human bone marrow or adipose tissue differently modulate mitogen-stimulated B-cell immunoglobulin production in vitro. Cell Biol Int 2008;32:384–393.
24. Williams K, Alvarez X, Lackner AA. Central nervous system perivascular cells are immunoregulatory cells thatconnect theCNS withthepe-ripheral immune system. Glia 2001;36:156–164.
25. Soubeyrand M, Badner A, Vawda R et al. Very high resolution ultrasound imaging for real-time quantitative visualization of vascular disruption after spinal cord injury. J Neurotrauma 2014;31:1767–1775.
26. Brown A, Nabel A, Oh W et al. Perfusion imaging of spinal cord contusion: Injury-induced blockade and partial reversal by b2-agonist treatment in rats. J Neurosurg Spine 2014;20:164–171.
27. Lee RH, Pulin AA, Seo MJ et al. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 2009;5:54–63.
28. Figley SA, Khosravi R, Legasto JM et al. Characterization of vascular disruption and blood-spinal cord barrier permeability following traumatic spinal cord injury. J Neurotrauma 2014;31:541–552.
29. Warnick RE, Fike JR, Chan PH et al. Measurement of vascular permeability in spinal cord using Evans Blue spectrophotometry and correction for turbidity. J Neurosci Methods 1995;58:167–171.
30. Choudhri TF, Hoh BL, Solomon RA et al. Use of a spectrophotometric hemoglobin assay to objectively quantify intracerebral hemorrhage in mice. Stroke 1997;28:2296–2302.
31. Nguyen DH, Cho N, Satkunendrarajah K et al. Immunoglobulin G (IgG)attenuates neuroinflammation and improves neurobehavioral recovery after cervical spinal cord injury. J Neuroinflammation 2012;9:224.
32. Forgione N, Karadimas SK, Foltz WD et al. Bilateral contusion-compression model of incomplete traumatic cervical spinal cord injury. J Neurotrauma 2014;31:1776–1788.
33. Rivlin AS, Tator CH. Objective clinical assessment of motor function after experimental spinal cord injury in the rat. J Neurosurg 1977; 47:577–581.
34. Basso DM, Beattie MS, Bresnahan JC. A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma 1995;12:1–21.
35. Chen C-W, Okada M, Proto JD et al. Human pericytes for ischemic heart repair. STEM CELLS 2013;31:305–316.
36. Avolio E, Meloni M, Spencer HL et al. Combined intramyocardial delivery of human pericytes and cardiac stem cells additively improves the healing of mouse infarcted hearts through stimulation of vascular and muscular repair. Circ Res 2015;116:e81–e94.
37. Mendel TA, Clabough EBD, Kao DS et al. Pericytes derived from adipose-derived stem cells protect against retinal vasculopathy. PLoS One 2013;8:e65691.
38. Elenkov IJ, Wilder RL, Chrousos GP et al. The sympathetic nerve—an integrative interface between two supersystems: The brain and the immune system. Pharmacol Rev 2000; 52:595–638.
39. Lucin KM, Sanders VM, Jones TB et al. Impaired antibody synthesis after spinal cord injury is level dependent and is due to sympathetic nervous system dysregulation. Exp Neurol 2007;207:75–84.
40. Fleming JC, Bailey CS, Hundt H et al. Remote inflammatory response in liver is dependent on the segmental level of spinal cord injury. J Trauma Acute Care Surg 2012;72: 1194–1201; discussion 1202.
41. Zhang Y, Guan Z, Reader B et al. Autonomic dysreflexia causes chronic immune suppression after spinal cord injury. J Neurosci 2013;33:12970–12981.
42. Rosas-Ballina M, Ochani M, Parrish WR et al. Splenic nerve is required for cholinergic antiinflammatory pathway control of TNF in endotoxemia. Proc Natl Acad Sci USA 2008; 105:11008–11013.
43. Huston JM, Rosas-Ballina M, Xue X et al. Cholinergic neural signals to the spleen down-regulate leukocyte trafficking via CD11b. J Immunol 2009;183:552–559.
44. Acosta SA, Tajiri N, Hoover J et al. Intravenous bone marrow stem cell grafts preferentially migrate to spleen and abrogate chronic inflammation in stroke. Stroke 2015;46:2616–2627.
45. Vendrame M, Gemma C, Pennypacker KR et al. Cord blood rescues stroke-induced changes in splenocyte phenotype and function. Exp Neurol 2006;199:191–200.
46. Tang G, Liu Y, Zhang Z et al. Mesenchymal stem cells maintain blood-brain barrier integrity by inhibiting aquaporin-4 upregulation after cerebral ischemia. STEM CELLS 2014;32:3150–3162.
47. Yu DS, Liu LB, Cao Y et al. Combining bone marrow stromal cells with green tea polyphe-nols attenuates the blood-spinal cord barrier permeability in rats with compression spinal cord injury. J Mol Neurosci 2015;56:388–396.
48. Chen M, Li X, Zhang X et al. The inhibitory effect of mesenchymal stem cell on blood-brain barrier disruption following intracerebral hemorrhage in rats: Contribution of TSG-6. J Neuroinflammation 2015;12:61.
49. Honma T, Honmou O, Iihoshi S et al. Intravenous infusion of immortalized human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat. Exp Neurol 2006;199:56–66.
50. Iihoshi S, Honmou O, Houkin K et al. A therapeutic window for intravenous administration of autologous bone marrow after cerebral ischemia in adult rats. Brain Res 2004;1007:1–9.
51. Burchfield JS, Iwasaki M, Koyanagi M et al. Interleukin-10 from transplanted bone marrow mononuclear cells contributes to cardiac protection after myocardial infarction. Circ Res 2008;103:203–211.
52. Dayan V, Yannarelli G, Billia F et al. Mesenchymal stromal cells mediate a switch to alternatively activated monocytes/macrophages after acute myocardial infarction. Basic Res Cardiol 2011;106:1299–1310.
53. Min C-K, Kim B-G, Park G et al. IL-10-transduced bone marrow mesenchymal stem cells can attenuate the severity of acute graft-versus-host disease after experimental allogeneic stem cell transplantation. Bone Marrow Transplant 2007;39:637–645.
54. Choi J-J, Yoo S-A, Park S-J et al. Mesenchymal stem cells overexpressing interleukin-10 attenuate collagen-induced arthritis in mice. Clin Exp Immunol 2008;153:269–276.
55. Tsumuraya T, Ohtaki H, Song D et al. Human mesenchymal stem/stromal cells suppress spinal inflammation in mice with contribution ofpituitaryadenylatecyclase-activatingpolypep-tide (PACAP). J Neuroinflammation 2015;12:35.
56. Thompson CD, Zurko JC, Hanna BF et al. Thetherapeutic roleofinterleukin-10 after spinal cord injury. J Neurotrauma 2013;30:1311–1324.
57. Brewer KL, Bethea JR, Yezierski RP. Neuroprotective effects of interleukin-10 following excitotoxic spinal cord injury. Exp Neurol 1999; 159:484–493.
58. Knoblach SM, Faden AI. Interleukin-10 improves outcome and alters proinflammatory cytokine expression after experimental traumatic brain injury. Exp Neurol 1998;153: 143–151.
59. Mostafa Mtairag E, Chollet-Martin S, Oudghiri M et al. Effects of interleukin-10 on monocyte/endothelial cell adhesion and MMP9/TIMP-1 secretion. Cardiovasc Res 2001;49: 882–890.
60. Göritz C, Dias DO, Tomilin N et al. A pericyte origin of spinal cord scar tissue. Science 2011;333:238–242.
61. Birbrair A, Zhang T, Wang Z-M et al. Pericytes at the intersection between tissue regeneration and pathology. Clin Sci (Lond) 2015;128: 81–93.
62. Keating A. Mesenchymal stromal cells: New directions. Cell Stem Cell 2012;10:709–716.
63. Lv F-J, Tuan RS, Cheung KMC et al. Concise review: The surface markers and identity of human mesenchymal stem cells. STEM CELLS 2014;32:1408–1419.
64. Blocki A, Wang Y, Koch M et al. Not all MSCs can act as pericytes: Functional in vitro assays to distinguish pericytes from other mesenchymal stem cells in angiogenesis. Stem Cells Dev 2013;22:2347–2355.